SPIRIT-HF missed its primary composite endpoint at 2 years, with higher observed event rates on spironolactone versus placebo ...
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...
HF Sinclair’s Q4 2024 adjusted EPS dropped to $(1.02) from $0.87 YoY, missing estimates, while revenue rose to $6.50B. Adjusted EBITDA declined 93.5% YoY to $28M due to lower refining margins, but the ...
Researchers quantify the risk for heart failure among people who screen positive for atrial fibrillation and suggest ECG ...
LONDON, England—Use of the nonsteroidal mineralocorticoid receptor antagonist (MRA) finerenone cuts the risk of worsening HF events and cardiovascular mortality in patients who have heart failure with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results